These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3539066)

  • 41. A novel erythrocyte-based immunoassay for simultaneous detection of both antimycobacterial antibody response and mycobacterial antigen in human serum samples of pulmonary tuberculosis and a control group of patients using 'a single probe'.
    Katti MK; Mohammed Azeem S
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):134-7. PubMed ID: 16706796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reverse passive hemagglutination reaction for detecting hepatitis B virus surface antigens].
    Goroshnikov SB
    Mikrobiol Zh (1978); 1982; 44(3):47-51. PubMed ID: 7121320
    [No Abstract]   [Full Text] [Related]  

  • 43. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 44. [Trials to obtain conjugates for the passive hemagglutination test with chromium chloride and their use in studying foot-and-mouth disease viruses].
    Tekerlekov P; Nikolova E
    Vet Med Nauki; 1984; 21(7-8):15-21. PubMed ID: 6209849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serology of leprosy. I. Indirect hemagglutination test with stabilized sensitized red cells.
    Jagannath C; Sengupta DN
    Lepr India; 1981 Oct; 53(4):507-12. PubMed ID: 7334779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.
    Wu HC; Yeh CT; Huang YL; Tarn LJ; Lung CC
    Appl Environ Microbiol; 2001 Jul; 67(7):3201-7. PubMed ID: 11425742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Escherichia-erythrocyte diagnostic agents].
    Shamardin VA; Omirbaeva SM
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):72-5. PubMed ID: 2429482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of proteins, insoluble at low temperature, produced by Clostridium botulinum type C and C. subterminale. Their antigenic relationship with a similar protein synthesized by C. botulinum type G.
    Giménez JA; Vita N; Giménez DF; Paladini AC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):45-56. PubMed ID: 3314259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of the immunofluorescence test in the diagnosis of botulinum toxin poisoning in humans. III. Influence of toxinogenic and boticinogenic properties on the sensitivity and specificity of the immunofluorescence test].
    Anusz Z; Matras J; Mierzejewski J
    Przegl Epidemiol; 1976; 30(3):345-56. PubMed ID: 796891
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of group a streptococci by reverse passive hemagglutination.
    Edwards EA; Larson GL
    Immunol Commun; 1976; 5(1-2):41-51. PubMed ID: 780268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative immunochemical study of the hemagglutinins of Cl. botulinum A and B].
    Ivanova LG; Kliucheva VV; Blagoveshchenskiĭ VA; Lebedenko GI; Saprykina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):48-53. PubMed ID: 404806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Surface antigen of Clostridium botulinum. 3. Isolation and characterization of glycopeptide antigen of E type organism].
    Takumi K; Nagao S; Kawata T
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):83. PubMed ID: 765571
    [No Abstract]   [Full Text] [Related]  

  • 53. [An immunochemical study of serologically active substances isolated from Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):10-8. PubMed ID: 4969441
    [No Abstract]   [Full Text] [Related]  

  • 54. [Erythrocyte diagnostic agents for detecting bacterial antigens of the genus Citrobacter].
    Karal'nik BV; Sarbasova ShI; Zhuromskaia VA; Bisenova NM
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):63-8. PubMed ID: 2429481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effectiveness of erythrocytic diagnostic reagents in indicating Shigellae].
    Suslova MIu; Shamardin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):69-72. PubMed ID: 7158163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serological studies of Clostridium botulinum type E and related organisms.
    Lynt RK; Solomon HM; Kautter DA; Lilly T
    J Bacteriol; 1967 Jan; 93(1):27-35. PubMed ID: 5335894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glutaraldehyde stabilisation of antibody-linked erythrocytes for use in reverse passive and related haemagglutination assays.
    Cranage MP; Gurner BW; Coombs RR
    J Immunol Methods; 1983 Nov; 64(1-2):7-16. PubMed ID: 6315824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Conditions for erythocyte sensitization using chromium chloride in the passive hemagglutination reaction].
    Basmadzhian ME; Khzardzhian AM
    Zh Eksp Klin Med; 1979; 19(3):56-8. PubMed ID: 494888
    [No Abstract]   [Full Text] [Related]  

  • 59. [Identification of group B streptococci by an indirect hemagglutination method].
    Dziubak AP
    Veterinariia; 1977 May; (5):97-9. PubMed ID: 69359
    [No Abstract]   [Full Text] [Related]  

  • 60. [On a method of setting up the indirect hemagglutination test with antibody-sensitized erythrocytes].
    Baiar GA; Konikova RE; Krylov VN
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):97-102. PubMed ID: 4978070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.